跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 14,471 条关于
“degrader-antibody conjugate”
全部
14,471
临床试验
5,549
药物
2,855
机构
63
资讯
6,004
11个月前
Orum Therapeutics Strengthens Degrader-Antibody Conjugate Platform with Key Executive Appointment
8个月前
Orum Therapeutics Appoints Chad May as Chief Scientific Officer to Advance Degrader-Antibody Conjugate Platform
26天前
Orum Therapeutics Announces U.S. FDA Clearance of IND for ORM-1153, a First-in-Class CD123-GSPT1 Degrader-Antibody Conjugate
9个月前
Prelude Therapeutics Unveils Novel JAK2V617F-Selective Inhibitor and mCALR-Targeted Therapy for Myeloproliferative Neoplasms
3个月前
J&J Acquires Firefly Bio in $1 Billion Deal to Advance Pan-KRAS Degrader-Antibody Conjugates
5个月前
C4 Therapeutics and Roche Expand Partnership with $1 Billion+ DAC Collaboration
上个月
Johnson & Johnson's Oncology Pipeline Surge: Firefly Bio Acquisition, Sail Biomedicines CAR-T Deal, and OTTAVA Robotic System FDA Authorization
10个月前
Nurix Therapeutics Strengthens Board with Former Pfizer and Seagen Executive Roger Dansey
去年
Nurix Therapeutics Advances BTK Degrader NX-5948 and Reinitiates NX-2127 Trial
23小时前
BMS Halts Phase 1 ORM-6151 in AML and MDS, Returning Sole Clinical-Stage DAC to Orum Therapeutics
第 1 页，共 601 页
上一页
下一页
